Veronique Lecault - 07 Dec 2021 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Signature
/s/ Tryn Stimart, attorney in fact
Issuer symbol
ABCL
Transactions as of
07 Dec 2021
Net transactions value
$0
Form type
4
Filing time
09 Dec 2021, 17:01:56 UTC
Previous filing
03 Dec 2021
Next filing
09 Dec 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ABCL Common Shares 1,589,333 07 Dec 2021 Direct
holding ABCL Common Shares 7,155,008 07 Dec 2021 See Footnote F1
holding ABCL Common Shares 273,630 07 Dec 2021 See Footnote F2
holding ABCL Common Shares 61,580 07 Dec 2021 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABCL Share Option Award $0 +406,020 +16% $0.000000 2,930,154 07 Dec 2021 Common Shares 406,020 $14.55 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by Pacific Swell Capital Corp ("Pacific Swell"). The Reporting Person is a director of Pacific Swell and shares voting and dispositive power with respect to the shares held by Pacific Swell. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein.
F2 These shares are held by Slomo Family Trust. The Reporting Person is a co-trustee of the Slomo Family Trust. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein.
F3 The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on December 7, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date